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Abstract
Background: Systemic embolism, especially septic embolism, is a severe complication of infective endocarditis (IE).
However, concurrent embolism to the brain, coronary arteries, and spleen is very rare. Because of the risk of
hemorrhage or visceral rupture, anticoagulants are recommended only if an indication is present, e.g. prosthetic
valve. Antiplatelet therapy in IE is controversial, but theoretically, this therapy has the potential to prevent and treat
thrombosis and embolism in IE. Unfortunately, clinical trial results have been inconclusive.
Case presentation: We describe a previously healthy 50-year-old man who presented with dysarthria secondary to
bacterial endocarditis with multiple cerebral, coronary, splenic, and peripheral emboli; antibiotic therapy contributed
to the multiple emboli. Emergency splenectomy was performed, with subsequent mitral valve repair. Pathological
examination confirmed mucoid degeneration and mitral valve prolapse (Barlow’s disease) as the underlying
etiology of the endocardial lesion. Continuous antibiotics were prescribed, postoperatively. Transthoracic
echocardiography at 1.5, 3, and 6 months after the onset of his illness showed no severe regurgitation, and there
was no respiratory distress, fever, or lethargy during follow-up.
Conclusions: Although antibiotic use in IE carries a risk of septic embolism, these drugs have bactericidal and
antithrombotic benefits. It is important to consider that negative blood culture and symptom resolution do not
confirm complete elimination of bacteria. However, vegetation size and Staphylococcus aureus infection accurately
predict embolization. It is also important to consider that bacteria can be segregated from the microbicide when
embedded in platelets and fibrin. Therefore, antimicrobial therapy with concurrent antiplatelet therapy should be
considered carefully.
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Background
Systemic embolism, particularly septic embolism, is a se-
vere complication of IE. However, concurrent embolism
to the brain, coronary arteries, and spleen is very rare.
Because of the risk of hemorrhage or visceral rupture,
anticoagulants are recommended only if an indication
for anticoagulation is present [1], e.g. prosthetic valve.
Also, antiplatelet therapy in IE remains controversial,
with available clinical trials and animal experiments pro-
viding contradictory results. Theoretically, antiplatelet
therapy has the potential to inhibit and treat thrombosis
and embolism in IE. Unfortunately, the results of clinical
trials are inconclusive.
Case presentation
A 50-year-old man was admitted to our hospital with
acute-onset dysarthria. He presented febrile, with re-
spiratory distress and lethargy, and performed poorly in
the right hand alternating movement test. After finding
an obvious cardiac murmur, he was transferred to the
cardiology department, from the neurology department.
Physical examination revealed a blood pressure of 130/
90 mm Hg, and heart rate of 116 beats per minute. Car-
diac examination revealed that the apex beat was located
in the sixth intercostal space, 1.5 cm outside the midcla-
vicular line. Cardiac auscultation revealed a grade 4/6
systolic murmur that was most prominent at the apex.
Electrocardiography revealed sinus tachycardia without
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evidence of ischemia, and serum levels of troponin T,
creatine kinase (CK), and CK-myoglobin (CK-MB) were
normal; however, N-terminal-pro-brain natriuretic pep-
tide (NT-pro-BNP) levels were increased (3277 pg/ml).
The leukocyte count was 10620/mm3, with neutrophils
at 10 350/mm3. The erythrocyte sediment rate was
68 mm/h, and blood culture was positive for group A β-
hemolytic streptococcus. Transthoracic and transesopha-
geal echocardiography revealed rupture of the mitral
chordae tendineae, perforation of the leaflet, mitral vege-
tation measuring 40 × 30 mm, and severe regurgitation
(Fig. 1b and Additional file 1). The left ventricular cham-
ber was enlarged (left ventricular end-diastolic diameter:
64 mm; left ventricular end-systolic diameter: 45 mm),
and the pulmonary artery was dilated (diameter: 33 mm;
systolic pressure: 94 mm Hg). Cranial MRI revealed high
signal intensity in the left hemisphere, indicating cere-
bral infarction (Fig. 1a). Abdominal ultrasound showed
multiple echo-free areas in the spleen that suggested
splenic abscess formation (Fig. 1c), and multiple blood
cultures confirmed the presence of group A β-hemolytic
Streptococcus. A diagnosis of left-sided native valve IE
was made based on the modified Duke criteria, and the
patient’s body temperature was well-controlled by ceftri-
axone and vancomycin antibiotic therapy. However,
12 days after presentation, he complained of severe
retrosternal chest pain radiating to his back, with ECG
showing ST-segment elevation in V3, V4, and V5 leads
(Fig. 2a), and increased troponin T (0.542 ng/ml) and
CK-MB levels (25 u/l), confirming acute myocardial in-
farction (AMI). The mechanism of AMI secondary to IE
is either compression by aortic periannular lesions or
embolism [2]. Because his aorta was not involved, em-
bolism was a concern. Repeat echocardiography showed
left ventricular regional and segmental abnormal move-
ment during contraction, supporting AMI. We elected
not to initiate antiplatelet therapy, because of his cere-
bral infarction and splenic abscess, but valve surgery was
planned. Unfortunately, 2 days later, he experienced
acute-onset sharp abdominal pain with cold limbs, ten-
derness, muscle tension, guarding, hypotension, and
tachycardia, suggesting peritonitis and shock. Bedside
ultrasound revealed a 23-mm anechoic area in the ab-
dominal cavity, and intraperitoneal hemorrhage was
confirmed by abdominocentesis. Spontaneous splenic
rupture was confirmed on emergency laparotomy. A
necrotic area was seen in a section of the extracted
spleen (Fig. 3a), and necrotic tissue with massive neutro-
phil and macrophage infiltration was observed micro-
scopically, suggesting abscess formation secondary to
Fig. 1 Diagnostic findings. a. Cranial T2-magnetic resonance image showing high signal intensity in the left hemisphere (red arrow); b.
Echocardiograph clearly shows a sizeable vegetation on the mitral valve (red arrow); c. Abdominal ultrasound showing multiple echo-free
areas (red arrow) in the spleen, indicating liquefactive necrosis and abscess formation; d. Color Doppler showing severe
mitral regurgitation
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septic embolism (Fig. 3b). Mitral valvuloplasty was per-
formed after the patient’s presentation, with vegetation
resection, posterior valve repair, and flexible annulo-
plasty ring placement (Fig. 3c). Pathological analysis re-
vealed mucoid degeneration of the mitral valve,
inflammatory cell infiltration, and mural thrombus for-
mation (Fig. 3d). We diagnosed mucoid degeneration
and mitral valve prolapse (Barlow’s disease) as the
underlying etiology of the endocardial lesion. Transtho-
racic echocardiography 1.5, 3, and 6 months after the
onset of his illness showed no regurgitation, and there
was no respiratory distress, fever, or lethargy during
follow-up.
Conclusion
We described here an IE case with multiple systemic
embolism in infective endocarditis underlying in Bar-
low's disease. Although antibiotic use in IE carries a risk
of septic embolism, these drugs have bactericidal and an-
tithrombotic benefits. It is important to consider that
negative blood culture and symptom resolution do not
confirm complete elimination of bacteria. However,
vegetation size and Staphylococcus aureus infection ac-
curately predict embolization. It is also important to
consider that bacteria can be segregated from the micro-
bicide when embedded in platelets and fibrin. Therefore,
antimicrobial therapy with concurrent antiplatelet ther-
apy should be considered carefully.
Discussion
We report a unique IE case complicated by concurrent
cerebral infarction, acute myocardial infarction, and
splenic rupture. To our knowledge, a similar case has
not been reported previously. In a retrospective study of
IE, 499 of 1456 patients (34 %) were complicated by em-
bolic events. Prosthetic valve location, right-sided endo-
carditis, Staphylococcus aureus infection, and vegetation
size are considered high risk factors for embolism [3]. In
prospective cohorts, embolic events occurred in 34.1 %
[4], and 46 % [5] of patients, and age, sex, serum creatin-
ine, and C-reactive protein levels were considered add-
itional risk factors. In other studies [6], the incidence of
embolism was 8.5 %, and a formula was developed to de-
termine the likelihood of embolism, considering age, dia-
betes, atrial fibrillation, embolism before antibiotics,
vegetation size, and Staphylococcus aureus infection. Re-
sults showed that vegetation size and Staphylococcus
aureus infection validly predict embolization. In septic
Fig. 2 Electrocardiogram tracing. a. ST segment elevation in leads V3–V5 (arrow) combined with abnormal serum troponin T levels indicated
acute coronary syndrome; b. ST segment descends gradually to baseline
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embolism, antibiotics have dual effects including bacteri-
cidal and antithrombotic effects. However, systemic em-
bolism tends to take place in patients with embolism
before antibiotic treatment, increasing vegetation size
in spite of antimicrobial therapy, when Staphylococcus
spp are involved in the mitral valve vegetation [7].
Also, antibiotic regimes should be chosen carefully
because different antibiotics have different effects on
IE. One clinical study revealed that vancomycin and
ampicillin were associated with significant reduction
in vegetation size; however, cephalosporin and
penicillinase-resistant drugs were associated with in-
creased vegetation size and embolic risk [8]. Unfortu-
nately, negative blood culture and resolution of
clinical signs do not confirm bacterial elimination.
One reason may be drug resistance, and another may
be that antibiotics cannot access the center of the
vegetation. The vegetation consists of platelets, fibrin,
bacteria, and other components, and bacteria are seg-
regated from endogenous microbicides such as some
proteins, and exogenous antibiotics, by the platelets
and fibrin. The outer crust of the vegetation envelops
and confines the bacteria to prevent dissemination,
but this protects bacteria from being thoroughly elim-
inated [9, 10]. It is not currently known which
antibiotics perform better regarding anti-thrombosis;
therefore, the best future antibiotics will have both
good bactericidal effects, and good penetration into
the vegetation. Currently, careful consideration should
be given to whether concurrent antimicrobial therapy
and antiplatelet therapy is more beneficial than antibi-
otics alone. In vitro, platelet aggregation can be an-
tagonized by aspirin in the presence of bacteria
isolated from blood culture [11]. In vivo animal ex-
periments have shown that aspirin has antibacterial
effects in IE, inhibiting bacterial adhesion to platelets
and vegetation [12]. Aspirin has a dose-dependent ef-
fect on reducing vegetation size, with the greatest
benefit at middle doses. This is perhaps because lower
doses of aspirin do not completely inhibit platelets, while
higher doses also decrease prostacyclin, which inhibits
platelet aggregation. Regarding antiplatelet effects, aspirin
and ticlopidine equally reduce vegetation.
Antiplatelet therapy can dramatically diminish vege-
tation, when used with vancomycin. However, clinical
trials have shown contradictory effects of antiplatelet
therapy. Some researchers argue that aspirin reduces
stroke events, the number of patients requiring sur-
gery, or mortality, without increasing hemorrhagic
events [13–15]; however, these studies were
Fig. 3 Pathological and gross valve findings. a. Necrotic area (yellow arrow) and solid abscess (red arrow) were seen in a section of removed
spleen; b. Necrotic tissue and high neutrophil and macrophage infiltration (white arrow) were seen microscopically (magnification, ×200); c.
Valvular vegetation resected during heart surgery; d. Mucoid degeneration of the mitral valve, fibrinous exudation with inflammatory cell
infiltration, and mural thrombus formation are seen microscopically (magnification × 100)
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retrospective, and included small sample sizes. A pro-
spective randomized controlled trial showed that as-
pirin failed to reduce the risk of embolism [16].
Because the cyclooxygenase pathway is not the only
way to activate platelets, especially in endocarditis,
the activator may not be derived from thromboxane
A2; therefore, aspirin, which inhibits cyclooxygenase
to reduce thromboxane A2, may play a less important
role in IE. This theory may explain why aspirin per-
formed poorly in a prospective trial, and thus, the
need for more research regarding other antiplatelet
drugs with mechanisms different from aspirin, such
as clopidogrel, cilostazol, and ticagrelor, in preventing
and treating embolism in IE. Considering the findings
in current studies, antiplatelet therapy has potential
in IE therapy.
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